Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Murine marginal zone B cells play a role in Vibrio cholerae LPS antibody responses.

Wade WF, King RG, Grandjean C, Wade TK, Justement LB.

Pathog Dis. 2014 Mar;70(2):153-7. doi: 10.1111/2049-632X.12085. Epub 2013 Sep 12.

PMID:
23966359
2.

Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies.

Grandjean C, Wade TK, Ropartz D, Ernst L, Wade WF.

Pathog Dis. 2013 Mar;67(2):136-58. doi: 10.1111/2049-632X.12022. Epub 2013 Feb 25.

PMID:
23620159
3.

A one dose experimental cholera vaccine.

Muse M, Grandjean C, Wade TK, Wade WF.

FEMS Immunol Med Microbiol. 2012 Oct;66(1):98-115. doi: 10.1111/j.1574-695X.2012.00993.x. Epub 2012 Jun 21.

4.

Antibodies and immune effectors: shaping Gram-negative bacterial phenotypes.

Wade WF, O'Toole GA.

Trends Microbiol. 2010 Jun;18(6):234-9. doi: 10.1016/j.tim.2010.03.001. Epub 2010 Mar 30.

PMID:
20359893
5.

Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.

Wade TK, Wade WF.

Microbiol Immunol. 2008 Dec;52(12):611-20. doi: 10.1111/j.1348-0421.2008.00078.x. Erratum in: Microbiol 2009 Jan;53(1):58.

6.

Neuromyelitis optica pathogenesis and aquaporin 4.

Graber DJ, Levy M, Kerr D, Wade WF.

J Neuroinflammation. 2008 May 29;5:22. doi: 10.1186/1742-2094-5-22. Review.

7.

Progress towards development of a cholera subunit vaccine.

Taylor RK, Kirn TJ, Bose N, Stonehouse E, Tripathi SA, Kovác P, Wade WF.

Chem Biodivers. 2004 Jul;1(7):1036-57. Review.

PMID:
17191897
8.
9.

B-cell responses to lipopolysaccharide epitopes: Who sees what first - does it matter?

Wade WF.

Am J Reprod Immunol. 2006 Nov-Dec;56(5-6):329-36.

PMID:
17076677
10.

Immunogenicity of synthetic saccharide fragments of Vibrio cholerae O1 (Ogawa and Inaba) bound to Exotoxin A.

Wade TK, Saksena R, Shiloach J, Kovác P, Wade WF.

FEMS Immunol Med Microbiol. 2006 Nov;48(2):237-51. Epub 2006 Sep 29. Erratum in: FEMS Immunol Med Microbiol. 2007 Mar;49(2):313.

11.

Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates.

Saksena R, Ma X, Wade TK, Kovác P, Wade WF.

FEMS Immunol Med Microbiol. 2006 Jun;47(1):116-28. Erratum in: FEMS Immunol Med Microbiol. 2007 Mar;49(2):312.

12.
15.
16.

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.

Ahonen CL, Doxsee CL, McGurran SM, Riter TR, Wade WF, Barth RJ, Vasilakos JP, Noelle RJ, Kedl RM.

J Exp Med. 2004 Mar 15;199(6):775-84. Epub 2004 Mar 8.

17.

Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.

Dolan BP, Phelan TP, Ilkovitch D, Qi L, Wade WF, Laufer TM, Ostrand-Rosenberg S.

J Immunol. 2004 Jan 15;172(2):907-14.

18.

CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.

Frleta D, Noelle RJ, Wade WF.

J Leukoc Biol. 2003 Dec;74(6):1064-73. Epub 2003 Sep 2.

PMID:
12960264
19.

Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice.

Frleta D, Lin JT, Quezada SA, Wade TK, Barth RJ, Noelle RJ, Wade WF.

J Immunother. 2003 Jan-Feb;26(1):72-84.

PMID:
12514431
20.
21.

Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.

Chernyak A, Kondo S, Wade TK, Meeks MD, Alzari PM, Fournier JM, Taylor RK, Kovác P, Wade WF.

J Infect Dis. 2002 Apr 1;185(7):950-62. Epub 2002 Mar 19.

PMID:
11920320
22.
23.

Immune response genes modulate serologic responses to Vibrio cholerae TcpA pilin peptides.

Meeks MD, Wade TK, Taylor RK, Wade WF.

Infect Immun. 2001 Dec;69(12):7687-94.

25.

Molecular dynamics of point mutated I-A(k) molecules expressed on lymphocytes.

Munnelly HM, Brady CJ, Hagen GM, Horvat RD, Wade WF, Roess DA, Barisas BG.

Immunol Lett. 2001 Jul 2;77(3):187-96.

PMID:
11410253
26.

Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo.

Frleta D, Demian D, Wade WF.

Int Immunopharmacol. 2001 Feb;1(2):265-75.

PMID:
11360928
28.

Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions.

Miga AJ, Masters SR, Durell BG, Gonzalez M, Jenkins MK, Maliszewski C, Kikutani H, Wade WF, Noelle RJ.

Eur J Immunol. 2001 Mar;31(3):959-65.

29.

Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor gamma-chain signaling.

Shen L, van Egmond M, Siemasko K, Gao H, Wade T, Lang ML, Clark M, van De Winkel JG, Wade WF.

Blood. 2001 Jan 1;97(1):205-13.

PMID:
11133762
30.

The ins and outs of getting in: structures and signals that enhance BCR or Fc receptor-mediated antigen presentation.

Shen L, Lang ML, Wade WF.

Immunopharmacology. 2000 Sep;49(3):227-40. Review.

PMID:
10996020
31.

Rotational and lateral dynamics of I-A(k) molecules expressing cytoplasmic truncations.

Munnelly HM, Brady CJ, Hagen GM, Wade WF, Roess DA, Barisas BG.

Int Immunol. 2000 Sep;12(9):1319-28.

PMID:
10967027
32.

Mutations in specific I-A(k) alpha(2) and beta(2) domain residues affect surface expression.

Lang ML, Yadati S, Seeley ES, Nydam T, Wade TK, Gabriel JL, Yeaman G, Barisas BG, Wade WF.

Int Immunol. 2000 Jun;12(6):777-86.

PMID:
10837405
33.

Dynamics of molecules involved in antigen presentation: effects of fixation.

Barisas BG, Wade WF, Jovin TM, Arndt-Jovin D, Roess DA.

Mol Immunol. 1999 Aug;36(11-12):701-8.

PMID:
10593509
34.
35.

Dichotomy between naïve and memory CD4(+) T cell responses to Fas engagement.

Desbarats J, Wade T, Wade WF, Newell MK.

Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8104-9.

36.

Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation.

Yadati S, Nydam T, Demian D, Wade TK, Gabriel JL, Barisas BG, Wade WF.

Immunol Lett. 1999 Mar 15;67(1):47-55.

PMID:
10217205
37.

Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.

Nydam T, Wade TK, Yadati S, Gabriel JL, Barisas BG, Wade WF.

Int Immunol. 1998 Aug;10(8):1237-49.

PMID:
9723711
38.

Interferometric fringe fluorescence photobleaching recovery interrogates entire cell surfaces.

Munnelly HM, Roess DA, Wade WF, Barisas BG.

Biophys J. 1998 Aug;75(2):1131-8.

40.
41.

Truncated MHC class II cytoplasmic and transmembrane domains: effect on plasma membrane expression.

Wade WF, Khrebtukova I, Schreiber KL, McKean DJ, Wade TK.

Mol Immunol. 1995 Apr;32(6):433-46.

PMID:
7753052
42.

Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.

DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS, Watts TH.

J Exp Med. 1995 Mar 1;181(3):985-92.

43.

Class II cytoplasmic and transmembrane domains are not required for class II-mediated B cell spreading.

Wade WF, Dickman DK, Peterson D, McCluskey J, Khrebtukova I.

Immunol Lett. 1995 Jan;44(1):67-74.

PMID:
7721346
44.

MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton.

Chia CP, Khrebtukova I, McCluskey J, Wade WF.

J Immunol. 1994 Oct 15;153(8):3398-407.

PMID:
7930565
45.

Truncation of the A alpha chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells.

Wade WF, Ward ED, Rosloniec EF, Barisas BG, Freed JH.

Int Immunol. 1994 Oct;6(10):1457-65.

PMID:
7826938
46.
47.

Structural compartmentalization of MHC class II signaling function.

Wade WF, Davoust J, Salamero J, André P, Watts TH, Cambier JC.

Immunol Today. 1993 Nov;14(11):539-46. Review.

PMID:
8274197
48.

Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction.

Watts TH, Alaverdi N, Wade WF, Linsley PS.

J Immunol. 1993 Mar 15;150(6):2192-202.

PMID:
7680686
49.
50.

Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein.

Wade WF, Chen ZZ, Maki R, McKercher S, Palmer E, Cambier JC, Freed JH.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6297-301.

Supplemental Content

Support Center